Results 131 to 140 of about 210,319 (212)

Cost-effectiveness of three screening strategies for atrial fibrillation in Sri Lanka: a decision-tree modelling analysis using community-based prevalence data. [PDF]

BMJ Glob Health
Kanesamoorthy S, Abdali Z, Gooden TE, Vethanayagam SA, Uruthirakumar P, Kodippily C, Kumarendran B, Thomas N, Nirantharakumar K, Lip GYH, Guruparan M, Haniffa R, Rajendra S, Beane A, Subaschandren K, Jowett S, NIHR Global Health Research Group on Atrial Fibrillation Management.   +16 more
europepmc   +1 more source

Provincial stratification and equity-weighted cost-effectiveness of malaria vaccines in Zambia under climate variability. [PDF]

BMJ Public Health
Phiri AE.
europepmc   +1 more source

Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost-effectiveness modelling study. [PDF]

Diabetes Obes Metab
Ponnana SR, Zhang T, Sirasapalli SK, Chen Z, Dazard JE, Surya N, Elhussain S, Sivanantham K, Okyere R, Neeland IJ, Rajagopalan S, Deo SV.   +11 more
europepmc   +1 more source

Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial. [PDF]

Front Pharmacol
Ma Y, Lou Y, Chen M, Zeng Y.
europepmc   +1 more source

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia. [PDF]

JAMA Netw Open
Downen SS, Farag HM, Davies A, Okeke CM, Ben-Umeh KC, Yunusa I, Eguale T.   +6 more
europepmc   +1 more source

Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease. [PDF]

Front Public Health
Jiang X, Lv G, Mendes ME, Wu J, Yuan J, Lu ZK.   +5 more
europepmc   +1 more source

The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study. [PDF]

Am J Health Syst Pharm
Malone DC, Seheult R, Brixner D, Oderda G, Burnett BP, Biskupiak J.   +5 more
europepmc   +1 more source

Cost-Effectiveness of Early vs Delayed Belimumab Treatment for Systemic Lupus Erythematosus.

JAMA Netw Open
Hundal S, Cappelli J, Sjöwall C, Osman M, Touma Z, Parodis I, Goldberg SR, Netchiporouk E.   +7 more
europepmc   +1 more source

Cost-effectiveness analysis of hepatitis E screening and vaccination: targeting vulnerable populations in outbreak and sporadic settings in China. [PDF]

Emerg Microbes Infect
Liu H, Chen G, Jie Y, Jiang Y, Huang Y, Wang X, Hao C, Gu J, Zhang L, Li J.   +9 more
europepmc   +1 more source

Cost-utility and budget impact analysis of biosimilar trastuzumab for early-stage HER2-positive breast cancer in Thailand: an updated evaluation supporting expanded access. [PDF]

BMC Health Serv Res
Lochid-Amnuay S, Kongsakon R.
europepmc   +1 more source